MedTrace Logo

Mepitel Film Treatment for the Prevention and Cutaneous Toxicity Due to Radiotherapy

NCT02741258 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2022-07-05

No results posted yet for this study

Summary

This is a randomized study, mepitel vs standard of care for the prevention and skin toxicity due to radiotherapy in patients with post-surgery breast cancer.

Mepitel film will be placed on the skin of the patients just before the start of the radiotherapy and will be replaced once a week until the end of the radiotherapy. In case of skin toxicities mepitel film will be placed until resolution of toxicities.

Conditions

  • Post-surgery Radiotherapy

Interventions

DEVICE

Mepitel Film

Placement of Mepitel Film to prevent skin toxicity

DRUG

skin cream

cream to treat skin erythema due to radiotherapy

Sponsors & Collaborators

  • Dario Valcarenghi

    lead OTHER

Principal Investigators

  • Dario Valcarenghi · Oncology Institute of Southern Switzerland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02741258 on ClinicalTrials.gov